BioLargo, Inc.'s president and CEO Dennis Calvert was recently interviewed by SNN Live at two investor conferences. Mr. Calvert introduces BioLargo and discusses the company's progress in commercializing its advanced iodine platform technology. Video of both interviews can be accessed by clicking on the following links.
- Marcum's 3rd Annual MicroCap Conference in New York City on May 29th. https://www.youtube.com/watch?v=_4TsS1Ua0Yg
- The LD Micro Invitational 2014 in Bel Air, CA on June 4th. https://www.youtube.com/watch?v=rKKfVdRfhqo
About BioLargo, Inc.
BioLargo, Inc. (OTCQB: BLGO) makes life better by delivering technology-based products that help solve some of the world's most important problems that threaten water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. The subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter, a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo also owns a 50% interest in the Isan System, which was honored with a 'Top 50 Water Company for the 21st Century' award by the Artemis Project. The subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, and consumer markets, including the Nature's Best Solution® and Deodorall® brands. (www.OdorNoMore.com). The subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com), focuses on advanced wound care management and is preparing to make FDA 510(k) applications in 2014.